What will happen to her body when she is undergoing chemotherapy? What kind of pain will she have to go through? Is she mentally prepared for chemotherapy? Will chemotherapy affect her emotionally? The mind is occupied with ample thoughts and emotions when loved ones undergo chemotherapy, and, fear is the most distressing one.
1. Fear of losing hair:
Loss of hair is among the most common side effects of chemotherapy. Chemotherapy affects all the cells in the body including the healthy ones, especially the ones that grow rapidly. Here are a few more things you must know about hair loss and chemotherapy:
• Not everyone faces an equal amount of hair loss.
• The amount of hair loss, thinning, or falling of hair depends on the chemotherapy dosage and medication.
• Hair loss due to chemotherapy can be sudden or can be a slow process.
• Patients may either lose all the hair or just a part of it.
• It is possible to lose hair from all parts of the body; not just on the head.
2. Fear of chronic side effects:
A lot of people fear that chemotherapy leaves patients with chronic side effects, which might stay with them forever. This is not true for all patients and all kinds of cancers. Different patients experience varying lengths of side effects – some for weeks and months and some for years. The patient’s cancer care specialist might be able to share information about the long-term and short-term side effects and the tenure of side effects. Some side effects can also be treated with medication or therapy.
3. Fear of chemotherapy being physically painful:
Agreed, chemotherapy is painful. However, patients should know that certain pains caused by chemotherapy could be treated by the medication or by alternative therapies. As per cancer care experts, patients should remember that most often the anxiety of what is going to happen can psychologically heighten the perception of pain. The physical pain caused by chemotherapy doesn’t necessarily have to be as painful as considered to be.
4. Side effects of chemotherapy:
Some of the common side effects of chemotherapy are nausea, hair loss, constipation, anemia, weight loss, fertility problems, kidney problems, and so on. Having said this, patients need to know that:
• Every patient has different levels of side effects. Some patients might experience higher side effects than other patients.
• Certain side effects can be prevented with the help of extra care and medication.
• Some side effects have long term impact whereas some lasts for a shorter tenure.
Medical research and innovation have made it possible for some women to avoid chemotherapy. In India, 95% of cancer patients choose to undergo chemotherapy, whereas a large percentage of them can avoid it. Studies show that chemotherapy can be avoided in 70% early stage HER2 positive breast cancer patients.
Prognostic tests like CanAssist Breast helps the patients to know their breast cancer recurrence risk score and possibly avoid chemotherapy. It makes personalized treatment possible while keeping the costs down in low-risk cases.
Chemotherapy is a tough fight, but constantly telling yourself that you CAN make through it, is the best way to deal with the fear of chemotherapy. Remember, “This Too Shall Pass”!
What comes to your mind when you think about breast cancer? It would most probably be ‘chemotherapy,’ ‘fear of a long process of treatment,’ ‘high costs,’ the fear of cancer coming back, and so on. These thoughts can be controlled with the right knowledge and right breast cancer treatments.
Researchers and oncologists have made new and promising forms of treatment for breast cancer. It’s time to personalize your treatment!
Our test classiﬁes patients as ‘low-risk’ or ‘high-risk’ based on the patient’s breast cancer recurrence risks over five years. The clear-cut test result provides doctors with additional information that can be used for treatment planning.
CanAssist Breast is a test that helps to plan the ideal treatment by predicting the breast cancer recurrence risk within five years of surgery. The risk of recurrence is lesser in early-stage breast cancer (Stage 1 and Stage 2), and hence, it is important for doctors and the patients to plan out a suitable course of treatment based on the breast cancer recurrence risk score.
Until a few years back, oncologists and clinicians were deciding cancer treatments based on age, tumor size, node status, grade, ER, PR and HER2 status. OncoStem realized there was a gap in the decision-making paradigm and understanding the tumor biology to comprehend the cancer progression and its aggressiveness would significantly change treatments depending on an individual’s tumor biology.
Tests similar to CanAssist Breast have been based on genomic analysis, whereas CanAssist Breast involves proteomics analysis. The genomics method considers genes of interest in the genome of a cell, whereas CanAssist Breast’s proteomics technique studies the proteins of interest produced by the cell. A 5-year study by OncoStem Diagnostics, recently published online, explains the detailed analysis and results that lead to the test, CanAssist Breast.
Your tumor is different, just like you are, as an individual.
Doctors and oncologists have to know as much possible about your tumor for optimal and ideal treatment.
Artificial intelligence and machine learning is an emerging approach in the healthcare sector including the treatment of breast cancer. CanAssist Breast is the first such test developed in India, specifically for Indian patients. It determines the tumor’s biochemical fingerprint and assesses its aggressiveness. Assessing the tumor biology in detail, the test considers five key biomarkers that are involved in recurrence-related pathways in the cell. Based on this combined analysis performed by proteomics-based technology, the information is then assessed by a statistical algorithm that provides a score between 0 and 100 – whether the patient is at low-risk or high-risk for cancer recurrence. A ‘CAB risk score’ less than 15.5 indicates a low-risk. Depending on each patient’s unique CAB risk score, the doctors can thus plan an ideal treatment tailored to an individual’s patient.
A decision that doctors and patients must make:
‘Fear’ is the most shared and challenging emotion that cancer brings with it. However, fearful a patient might be; it is essential for the patients to know and consider that their treatment can be different from that of the other patients.
Knowing who is eligible for the CanAssist-Breast test can help both patients and doctors. ‘
The patients must meet the below criteria to take CanAssist Breast:
- Patients with early-stage, invasive breast cancer
- Patients with hormone receptor-positive (“ER+ and/or PR+”) and HER2- negative disease
- Lymph node-negative or up to 3 lymph node-positive
- Patients should not have gone through neo-adjuvant chemotherapy
In India alone, 150,000 women are diagnosed with breast cancer every year. Of these, around 50 percent fall in the early-stage breast cancer category and a majority of them are eligible for this test.
Take your decision together
If you or someone among your friends or family are going through breast cancer (early-stage), you must consider taking CanAssist Breast before starting the treatment. If you are an oncologist or a doctor, maybe your patients could avoid the unnecessary treatments and the side effects most usually associated with chemotherapy.
Doctors must suggest the test to their eligible patients and patients must ask their doctors about the test score and personalize their treatment accordingly.
Want to know more about CanAssist Breast? Get in touch with us.
Women in their 30s/40s can and do get breast cancer, raising the need for young women to be breast aware. According to the American Cancer Society (ACS), 1 in 8 women is diagnosed with breast cancer at some point during their lives. Having said this, not all the lumps are cancerous. Here are a few things that you must consider to get started with breast cancer:
Your breasts can speak to you
Most of the women experience breast cancer symptoms such as a painless lump or mass, skin irritation, an inward turning nipple; pain in the nipple or breast; nipple discharge, thickening of the nipple or breast skin, scaliness, redness, and breast swelling. But, how many of us pay attention to these symptoms?.
If you are experiencing any of these symptoms, bring it to your doctor’s attention.
You might not have any family history of breast cancer, but that can’t be an assurance of you not getting diagnosed with breast cancer. As per the American Cancer Society, more than 85 percent of women who get breast cancer have no family history of cancer. Most of the women who find a lump in the breast think they needn’t worry as they have no family history of cancer. But, the truth is that even if you have no family history, you are still at risk of getting breast cancer over your lifetime.
High-risk factors are relative
The term ‘high risk’ is scientifically used by oncologists to determine the chances of cancer. There is no standard definition of what truly constitutes high-risk. It means that someone has a higher cancer risk than someone without any risk factors.
Here are a few breast cancer risk factors as per the National Cancer Institute:
· Excess alcoholism
· Getting your first menstrual period before age 12
· Giving birth for the first time after age 30
· Never being pregnant
· Starting menopause at an older age
· Having a close relative with breast cancer
Regular mammograms are a must
Some experts believe forty is the right age to get mammograms whereas a few recommend that women over fifty years must get mammograms once every two years. As breast cancer is age-related, most women prefer mammograms once they are in their fifties. However, considering the overall health of women, it’s better women start annual mammograms once they’re in their forties.
Talk to your doctor about when you should start getting mammograms and how often you should get them.
Breast self-examination is a preventive measure
Taking a monthly breast self-exam will serve as a preventive measure. Earlier the detection of breast cancer, better is the treatment planning. Regular breast self-exams will let you know the presence of lumps (if any), and you can consult an oncologist accordingly.
Have a say? Comment below.